ARYA Sciences Acquisition V in a press release said it will redeem shares and cease operations, effective July 14.
The per-share redemption price will be approximately $10.37. The balance of the trust as of June 30 was about $155 million.
The SPAC launched with an IPO two years ago. Arya V was focused on the healthcare industry in the United States and other developed countries. The company was targeting businesses with valuations of $300 million to $500 million or more and that have the potential for $1 billion or more market capitalization, but never announced a deal. Read more.
